view transcript

Botox, also known as botulinum toxin, is a powerful poison produced by the bacterium Clostridium botulinum.

1890s


Belgian scientist Emile Pierre van Ermengem was the first to discover Botox after a botulism outbreak in Belgium.


1970s

Scientists began using botulinum toxin to treat strabismus (crossed eyes) and muscle spasms.

1987

Vancouver doctors Jean and Alistair Carruthers discovered cosmetic properties in the treatment.

1989

Allergan licensed the treatment and branded it as Botox.

2002

The FDA approved the use of Botox for cosmetic purposes.


2006

Botox sales soared past the $1 billion mark worldwide, with cosmetic uses accounting for about half of sales.

2018

Cosmetic Botox U.S. sales reached a total of $907 million.

(source: www.SEC.gov)


Allergan's Botox faces competition with Merz Pharmaceuticals' Xeomin and Valeant's Dysport.


Allergan's plan to stay ahead relies on millennials taking up medical beauty procedures.

 

Lots of people might not have heard about Allergan (AGN - Get Report) but when it comes to Botox, they know what that is.

Let's rewind a bit.

Botox, also known as botulinum toxin, is a powerful poison produced by the bacterium Clostridium botulinum. Scientists began using botulinum toxin to treat strabismus (crossed eyes) and muscle spasms.

Then in 1987, Vancouver doctors Jean and Alistair Carruthers discovered cosmetic properties in the treatment.

Soon after, the American global pharmaceutical company Allergan licensed the treatment and branded it as Botox.

Botox has been a household name, especially in the field of cosmetic beauty, after the FDA approved its use in 2002. It is popular for its ability in reducing facial wrinkles.

Watch the video to find out more about the beauty secret.

Related. AbbVie Buys Allergan for $63 Billion: Was the Price Just Right?

Related. Think AbbVie Is Overpaying for Allergan? Pfizer Offered Way More in 2015 

This article was written by a staff member of TheStreet.